Symbol="MRTX"
AssetType="Common Stock"
Name="Mirati Ther"
Description="Mirati Therapeutics, Inc., a clinical-stage oncology company, develops candidate products to address the genetic and immunological promoters of cancer in the United States. The company is headquartered in San Diego, California."
CIK="1576263"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1974281000"
EBITDA="-765819008"
PERatio="None"
PEGRatio="0"
BookValue="14.84"
DividendPerShare="0"
DividendYield="0"
EPS="-12.21"
RevenuePerShareTTM="0.332"
ProfitMargin="0"
OperatingMarginTTM="-40.71"
ReturnOnAssetsTTM="-0.392"
ReturnOnEquityTTM="-0.698"
RevenueTTM="18894000"
GrossProfitTTM="-519791000"
DilutedEPSTTM="-12.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="9.11"
AnalystTargetPrice="65.07"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="207.59"
PriceToBookRatio="2.129"
EVToRevenue="106.31"
EVToEBITDA="-1.69"
Beta="0.958"
num_52WeekHigh="101.3"
num_52WeekLow="33.57"
num_50DayMovingAverage="40.24"
num_200DayMovingAverage="49.86"
SharesOutstanding="58187000"
DividendDate="None"
ExDividendDate="None"
symbol="MRTX"
open="34.43"
high="34.49"
low="33.57"
price="33.93"
volume="809776.00"
latest_trading_day="2023-07-18"
previous_close="34.50"
change="-0.57"
change_percent="-1.6522%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="77"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="23"
Volume_recent_avg="1020605"
Change_recent_avg="-0.08"
Delta_recent_avg="1.98"
Variance_recent_avg="0.99"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="23"
Aroon_momentum_negative="77"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="692"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
